Patient and physician convenience and the choice of intravitreal anti-vascular endothelial growth factor medications

John T. Thompson

doi:10.1001/jamaophthalmol.2015.4115

Patient and physician convenience and the choice of intravitreal anti-vascular endothelial growth factor medications

John T. Thompson

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	49-50
Number of pages	2
Journal	JAMA ophthalmology
Volume	134
Issue number	1
DOIs	https://doi.org/10.1001/jamaophthalmol.2015.4115
State	Published - Jan 2016

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1001/jamaophthalmol.2015.4115

Cite this

@article{46f018f5c2da44028fe4c547416b63bf,

title = "Patient and physician convenience and the choice of intravitreal anti-vascular endothelial growth factor medications",

author = "Thompson, {John T.}",

year = "2016",

month = jan,

doi = "10.1001/jamaophthalmol.2015.4115",

language = "English (US)",

volume = "134",

pages = "49--50",

journal = "JAMA ophthalmology",

issn = "2168-6165",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - Patient and physician convenience and the choice of intravitreal anti-vascular endothelial growth factor medications

AU - Thompson, John T.

PY - 2016/1

Y1 - 2016/1

UR - http://www.scopus.com/inward/record.url?scp=84958536702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958536702&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2015.4115

DO - 10.1001/jamaophthalmol.2015.4115

M3 - Comment/debate

C2 - 26540479

AN - SCOPUS:84958536702

SN - 2168-6165

VL - 134

SP - 49

EP - 50

JO - JAMA ophthalmology

JF - JAMA ophthalmology

IS - 1

ER -

Patient and physician convenience and the choice of intravitreal anti-vascular endothelial growth factor medications

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this